Cytox Ltd

Spare a thought. Maybe drop some coins in a collection box.

At the Alzheimer's Association International Conference (AAIC) 2023 held in Amsterdam, exciting results concerning our genoSCORE technology were presented:

1) An assessment of the utility of the technology to characterise risk for AD from Abbvie Inc - A polygenic risk score (PRS) predicts cognitive decline in the APOE3 population in an early Alzheimer's disease clinical trial cohort - Vasanthakumar et al.

2) The first report demonstrating viability in a non-Caucasian population - Evaluation of the performance of genoSCORE for predicting onset of Alzheimer's disease in a Japanese population - Gao et al.

Thanks to all our collaborators for advancing the use of genoSCORE

Another good day.

Drug donanemab seen as turning point in dementia fight The antibody treatment donanemab slows clinical decline by around a third, a large trial confirms.

Exciting news! 🎙️🧬 Don't miss the radio interview featuring Dr. Richard Pither, CEO of Cytox, as he discusses the game-changing benefits of genetic testing for Alzheimer's disease on The D Word, the UK's only dementia-based radio show! 🎧 Tune in to gain valuable insights from Dr. Richard Pither himself on how this groundbreaking test has been developed and its potential to revolutionise Alzheimer's prevention. Tune in here:
khealthradio.com/blog/episode/on-the-d-word-this-week-is-richard-pither-talking-about-a-new-genetic-test-which-predicts-lifetime-risk-of-developing-alzheimers/

On The ‘D’ Word this week is Richard Pither talking about a new Genetic Test which predicts lifetime risk of Developing Alzheimer’s «

FDA Panel Recommends Full Approval for New Alzheimer's Drug in June, Alzheimer's & Brain Awareness Month Alzheimer's & Brain Awareness Month brings exceptional news from the FDA recommending full approval of a new Alzheimer's drug, Leqembi.

Interesting article in Scientist Live highlighting that 'predictive genomics has the power to enable a shift from reactive to pre-emptive healthcare'. Very much our opinion too.

The power of predictive genomics | Scientist Live Predictive genomics provides the power to transform healthcare globally, explains Kim Caple

Come and talk to us about the Alzheimer's Risk Test at the American Academy of Neurology Conference - we're at booth 1664!

Interesting article in the LA Post Examiner.

Should everyone know their personal risk of developing Alzheimer's disease? - Los Angeles Post-Examiner Listen to this article Over the past few months, there have been two big stories in the news concerning Alzheimer’s

The Alzheimer's Risk Test is available at First Choice Neurology clinics across Florida, and also via telehealth platform, Neuro2Go. https://neuro2go.com/schedule-a-neurologist-virtual-visit/

The Alzheimer's Risk Test is available at First Choice Neurology clinics across Florida, or via the Neuro2Go virtual consultation platform. https://neuro2go.com/schedule-a-neurologist-virtual-visit/

Genetic Alzheimer’s Risk Test Genetic Alzheimer’s Risk Test - Did you know that there is a new test to detect your risk of getting Alzheimer’s disease?

Breaking news! A study from the University of Exeter in the UK shows adopting a Mediterranean diet may lower dementia risk by up to a quarter. And this 'protective effect' occurs 'regardless of a person's genetic risk'. This reinforces previous research that showed it is 'genes + environment' that determine overall risk for dementia.
The value of knowing your personal genetic risk lies in how it helps someone understand the importance of actively managing health and lifestyle factors.

Mediterranean diet may lower dementia risk by a quarter, study suggests Data from more than 60,000 Britons suggests plant-rich diet may help regardless of person’s genetic risk

Genetic Alzheimer’s Risk Test Genetic Alzheimer’s Risk Test - Did you know that there is a new test to detect your risk of getting Alzheimer’s disease?

In 2020, the Lancet Commission identified 12 potentially modifiable health and lifestyle factors on how best to manage or even prevent dementia. It was suggested if all of these factors could be successfully acted upon across the population we might see a 40% reduction in dementia cases.
https://www.raceagainstdementia.com/2021/01/12-modifiable-risk-factors-that-could-reduce-dementia-globally-by-40/
The Alzheimer’s Risk Test, powered by genoSCORE™ calculates an individual’s personal genetic risk from a simple saliva sample. State-of-the-art DNA profiling looks at over 100,000 genetic variations to work out a risk score, which can guide future lifestyle and wellbeing decisions, or help plan treatment. Knowing your personal genetic risk helps you assess the importance of managing health and lifestyle factors.

12 modifiable risk factors that could reduce dementia globally by 40% - Race Against Dementia 12 risk factors have been identified which, if mitigated, could reduce future cases of dementia by 40% globally. Some are more difficult than others to avoid but there are things that you can do to reduce your risk of dementia. The 12 risk factors are: Early life: Less education – higher and longe...

In an interview on WPBF25 news earlier this month, Dr Jennifer Buczyner, a board-certified neurologist at Comprehensive Neurology of the Palm Beaches, Florida described the Alzheimer’s Risk Test, ‘We look at all your genes and tell you in your 30s and 40s what your risk of [Alzheimer’s] dementia may be down the road’.
When asked about possible uses of Lecanemab, recently approved by the FDA, she went onto say, ‘The key is intervening. If we start intervening earlier there’s so much more that we can offer in the hope to slow this down. Don’t wait until [you or] your family member is way beyond mild cognitive impairment. We want to intervene when its early and we have so many more tools that can be helpful’. https://www.alzheimers-risk-test.com/alzheimers-risk-test

We’re pleased to announce that Neuro2Go, an online neurology service that offers a convenient way to talk to a board-certified neurologist, will now offer the Alzheimer’s Risk Test, powered by genoSCORE™ to anyone who wishes to know their personal genetic risk for AD. This collaboration extends the use of the Alzheimer’s Risk Test into telehealth, a fast-growing sector of the US healthcare market. More information at alzheimers-risk-test.com or schedule a NeuroChat at https://neuro2go.com/schedule-a-neurologist-virtual-visit/

Lecanemab, Eisai and Biogen’s new beta-amyloid-targeted Alzheimer’s drug has this week been approved by the FDA for use in the United States. A true milestone event in the journey towards the goal of treatability for this debilitating disease. Cytox joins with the rest of the AD community in celebrating this moment. As new therapies emerge identifying those most likely to benefit will be important. The Alzheimer’s Risk Test, powered by genoSCORE, enables anyone wishing to know their personal risk for AD and take control of their long-term health. More information at www.alzheimers-risk-test.com (US) or www.genoscore-lab.com (UK).

Home - genoSCORE-LAB genoSCORE™-LAB is a new non-invasive test that can predict the risk of an individual developing Alzheimer’s disease from a simple saliva sample. 

You’ve probably seen a fair bit in the news about Alzheimer’s disease recently, and maybe you’ve considered whether everyone who chooses should know their personal risk of developing the condition. If its possible, and it is, and if there are ways to reduce its impact, there are, and drugs to treat it, they’re beginning to emerge, then wouldn’t it be better to know your risk and take control? https://gbr01.safelinks.protection.outlook.com/?url=http%3A%2F%2Fshorturl.at%2FlprJ2&data=05%7C01%7C%7C39b5d18638f44e8a2f1c08dadd33c949%7Cadffc92d17e24db88bdb18b4fadc31e9%7C0%7C0%7C638065511766280491%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=PrBo1uSiwLU7FGpXrd%2BwCsAmPthbTiX%2B74n1aqG%2FwNY%3D&reserved=0

For Patients | IntellxxDNA A DNA-precise health plan designed to help you live your best life. Find a Provider The Book Of You No matter your age, race or gender, understanding your genomic profile provides a guide for you and your clinician in the care of your body and mind. Your clinician can use an IntellxxDNA test to prov...

In a conversation with our CEO, Dr Richard Pither, about the breaking news from Eisai, Professor Sir John Hardy of UCL said “Polygenic risk testing is able to be used at the earliest possible time to identify those most likely to benefit from future interventions, including lifestyle and environmental risk avoidance, management of co-morbidities and ultimately, use of disease-modifying drugs such as Lecanemab”.

We're pleased to announce that First Choice Neurology, the largest neurology group in the US, is offering the Alzheimer's Risk Test, developed by US company, Sampled, based on genoSCORE technology originated by Cytox Ltd. According to FCN Miami-based neurologist Dr. Jeff Gelblum, the Alzheimer’s Risk Test could transform physicians’ ability to predict and manage the disease. “This new genetic test is CLIA-accredited and uses a polygenic risk score (PRS), which accesses the accumulation of thousands of small genetic variations to determine Alzheimer’s risk,” he explained. “Tests that use only one gene marker for Alzheimer’s are not reliable predictors. This new test gives us actionable knowledge to be able to help patients manage their health". For more information on the test go to: https://alzheimers-risk-test.com

Kudos to Chris Hemsworth for speaking out about his Alzheimer’s risk status – properly Thor-like. We also believe that knowing your personal risk is a first step in taking control. Knowledge is power, after all. The Alzheimer’s Risk Test, powered by genoSCORE, assesses over 100,000 bits of your DNA to compute a single genetic risk score. All from a saliva sample. Find out more at https://alzheimers-risk-test.com/prevention

Most people don’t think about the risks of Alzheimer’s before symptoms set in, but the damage to the brain begins years or even decades prior 🧠

Expand on your knowledge of Alzheimer’s so you can take the right steps to decrease the risks here 👉 https://www.alzheimers-risk-test.com/prevention

Alzheimer’s disease doesn’t show symptoms until decades after changes to the brain have already started. So if you leave it late, it could be too late.

Find out how our genoSCORE-LAB test analyses genotypes and calculates the cognitive decline risk. By acting fast you can support your loved ones make the right changes to reduce their risk of Alzheimer’s.

Find out more here 👉 https://www.alzheimers-risk-test.com/worried-about-loved-ones

There are many ways you can reduce the risk or slow down the onset of Alzheimer’s disease.

Learn what you can do to better your outcomes here 👇 https://www.alzheimers-risk-test.com/prevention